MedPath
HSA Approval

ACTIMIN TABLET

SIN03927P

ACTIMIN TABLET

ACTIMIN TABLET

March 2, 1990

DUOPHARMA (SINGAPORE) PTE LTD

DUOPHARMA (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDUOPHARMA (SINGAPORE) PTE LTD
Licence HolderDUOPHARMA (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R01BA52

pseudoephedrine, combinations

Manufacturer Information

DUOPHARMA (SINGAPORE) PTE. LTD.

DUOPHARMA (M) SDN BHD

Active Ingredients

PSEUDOEPHEDRINE HCl

60 mg

Pseudoephedrine

TRIPROLIDINE HCl

2.5 mg

Triprolidine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACTIMIN TABLET - HSA Approval | MedPath